康芝药业：关于控股股东协议转让公司部分股权暨权益变动的提示性公告

Core Viewpoint - Kangzhi Pharmaceutical announced a share transfer agreement where its controlling shareholder, Hongshi Investment, will transfer 22,758,000 shares (5.0004% of total shares) to Chenle Jixiang No. 4 at a price of 5.34 RMB per share, totaling approximately 121.53 million RMB [2] Summary by Relevant Sections - Share Transfer Details - Hongshi Investment will transfer 22,758,000 unrestricted circulating shares to Chenle Jixiang No. 4 [2] - The transfer price is set at 5.34 RMB per share, amounting to a total of 121.53 million RMB [2] - Impact on Shareholding Structure - Post-transfer, Hongshi Investment's shareholding will decrease from 27.2538% to 22.2534% [2] - Chenle Jixiang No. 4 will become a shareholder with over 5% ownership [2]